Table 4.

Presumed incidence of infection among 336 Mexican soldiers with 10 most frequently detected individual HPV DNA and for groups according to oncogenicity

TypeNo. incident casesNo. men at riskMen-months of follow-upRate/1,000 men-months (95% CI)
5973113,7321.9 (0.8-3.9)
52153193,8283.9 (2.2-6.5)
1693203,8402.3 (1.1-4.4)
51103223,8642.6 (1.2-4.8)
5343263,9121.0 (0.3-2.6)
5883243,8882.1 (0.9-4.1)
3953243,8881.3 (0.4-3.0)
693273,9242.3 (1.0-4.4)
1853273,9241.3 (0.4-3.0)
8443133,7561.1 (0.3-2.7)
Oncogenic342382,85611.9 (8.2-16.6)
Nononcogenic342683,21610.6 (7.3-14.8)
All types452102,52017.9 (13.0-23.9)